Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma

Published:2014-03-17 Issue:11 Volume:55 Page:2514-2519
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kobayashi Yujin¹,Hatta Yoshihiro¹,Sugitani Masahiko²,Hojo Atsuko¹,Nakagawa Masaru¹,Kusuda Machiko¹,Uchino Yoshihito¹,Takahashi Hiromichi¹,Kiso Satomi¹,Hirabayashi Yukio¹,Yagi Mai¹,Kodaira Hitomi¹,Kurita Daisuke¹,Miura Katsuhiro¹,Iriyama Noriyoshi¹,Kobayashi Sumiko¹,Kura Yoshimasa³,Horikoshi Akira¹,Sawada Umihiko³,Takeuchi Jin¹,Takei Masami¹

Affiliation:

1. Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

2. Department of Pathology, Nihon University School of Medicine, Tokyo, Japan

3. Department of Hematology and Oncology, Kasukabe Municipal Hospital, Saitama, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.889827

Reference28 articles.

1. Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era